Table 3.
Hepatitis C virus in patients with liver disease
| S. # | Year | Place | Method | Sample size | Seroprevalence (%) | Ref. | ||||
| Hepatocellular carcinoma | ||||||||||
| 1 | 2009 | Punjab/KPK | ELISA1 | 145 | 76.5 | [97] | ||||
| 2 | 2009 | Pakistan | EIA2 | 82 | 79.2 | [98] | ||||
| 3 | 2010 | Karachi | -5 | 40 | 50 | [94] | ||||
| 4 | 2013 | Pakistan | ELISA4 | 645 | 48.5 | [95] | ||||
| 5 | 2014 | Hyderabad | ELISA4 | 188 | 66 | [96] | ||||
| Liver disease | AH | CH/CLD | Carrier | Cirrhosis | ||||||
| 6 | 2009 | Swat | ELISA4 | 110 | - | - | - | 63.6 | [99] | |
| 7 | 2009 | Pakistan | EIA2 | 107 | - | 62.6 | - | 24.3 | [98] | |
| 8 | 2010 | Karachi | -5 | 5153 | 7 | 72.9 | 51.7 | 59.4 | [94] | |
| Hepatic encephalopathy | ||||||||||
| 9 | 2009 | Hyderabad | -5 | 87 | 66.67 | [100] | ||||
| Suspected for viral hepatitis | ||||||||||
| 10 | 2014 | Islamabad | ELISA3 | 845 | 24.8 | [101] | ||||
1
DRG Instruments, Germany;
2
Abbott Diagnostics;
3
Biokit;
4
Manufacturer not mentioned in cited reference;
5
Method not mentioned in cited reference. AH: Acute hepatitis; CH: Chronic hepatitis; CLD: Chronic liver disease; ELISA: Enzyme linked immunosorbent assay; EIA: Enzyme immunoassay; KPK: Khyber Pakhtunkhwa.